Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Shares Outstanding (Weighted Average) (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $46.0 million as the latest value for Q1 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 0.59% to $46.0 million in Q1 2025 year-over-year; TTM through Mar 2025 was $46.0 million, a 0.59% increase, with the full-year FY2024 number at $45.8 million, changed 0.44% from a year prior.
  • Shares Outstanding (Weighted Average) was $46.0 million for Q1 2025 at KORU Medical Systems, roughly flat from $45.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $46.0 million in Q1 2025 to a low of $44.0 million in Q1 2021.
  • A 5-year average of $45.2 million and a median of $45.5 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): grew 10.8% in 2021, then rose 0.44% in 2024.
  • KORU Medical Systems' Shares Outstanding (Weighted Average) stood at $44.4 million in 2021, then increased by 1.39% to $45.0 million in 2022, then rose by 1.33% to $45.6 million in 2023, then rose by 0.44% to $45.8 million in 2024, then grew by 0.39% to $46.0 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Shares Outstanding (Weighted Average) are $46.0 million (Q1 2025), $45.8 million (Q4 2024), and $45.8 million (Q3 2024).